Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 1059Neoplasms 885Prostatic Neoplasms 510Lung Neoplasms 426Colorectal Neoplasms 358Motor Activity 226Uterine Cervical Neoplasms 194Head and Neck Neoplasms 194Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 174Pancreatic Neoplasms 162Ovarian Neoplasms 143Colonic Neoplasms 140Carcinoma, Hepatocellular 136Anxiety Disorders 125Rectal Neoplasms 119Hematologic Neoplasms 115Multiple Myeloma 109Stomach Neoplasms 105Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Pain 89Urinary Bladder Neoplasms 88Endometrial Neoplasms 87Glioblastoma 86Disease 85Lymphoma 84Sarcoma 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Adenocarcinoma of the Prostate × 1 year × Clear all
NCT02761889 2026-05-12

Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer

Fundacao Champalimaud

Phase NA Completed
444 enrolled
Genitourinary

Adenocarcinoma of the Prostate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡